Quarterly ResultJul 30, 2026, 04:18 PM
Merit Medical Q2 Revenue $418.8M, EPS $0.65; Raises FY26 Guidance
AI Summary
Merit Medical Systems, Inc. announced strong financial results for the second quarter of 2026, exceeding expectations with reported revenue of $418.8 million, up 10% year-over-year, and GAAP diluted EPS of $0.65, up 20%. The company also saw improvements in both GAAP and non-GAAP operating margins. Following this performance, Merit Medical raised its full-year 2026 revenue guidance to $1.631-$1.643 billion and non-GAAP EPS guidance to $4.25-$4.35, reflecting confidence in continued growth and profitability. The company will host a conference call to discuss these results.
Key Highlights
- Q2 2026 reported revenue was $418.8 million, an increase of 10% year-over-year.
- Q2 2026 GAAP diluted EPS was $0.65, an increase of 20% year-over-year.
- Q2 2026 non-GAAP diluted EPS was $1.19, an increase of 18% year-over-year.
- Q2 2026 GAAP operating margin improved to 14.4% from 12.3% in prior year.
- Full-year 2026 revenue guidance raised to $1.631-$1.643 billion (8% YoY growth).
- Full-year 2026 non-GAAP EPS guidance raised to $4.25-$4.35 (11-14% YoY growth).
- Year-to-date cash flow from operations was $110.0 million, down 11% YoY.
- Year-to-date free cash flow was $76.6 million, down 14% YoY.
Price Impact
More from MMSI